Begin typing your search above and press return to search.
proflie-avatar
Login
exit_to_app
The smouldering of anger in Ladakh
access_time 29 March 2024 4:20 AM GMT
Democracy that banks on the electorate
access_time 28 March 2024 5:34 AM GMT
Lessons to learn from Moscow terror attack
access_time 27 March 2024 6:10 AM GMT
Gaza
access_time 26 March 2024 4:34 AM GMT
The poison is not in words, but inside
access_time 25 March 2024 5:42 AM GMT
DEEP READ
Schools breeding hatred
access_time 14 Sep 2023 10:37 AM GMT
Ukraine
access_time 16 Aug 2023 5:46 AM GMT
Ramadan: Its essence and lessons
access_time 13 March 2024 9:24 AM GMT
When ‘Jai Sree Ram’ becomes a death call
access_time 15 Feb 2024 9:54 AM GMT
exit_to_app
covishield
cancel
camera_alt

representational image only

Homechevron_rightIndiachevron_rightIndia warns of...

India warns of 'reciprocal measures" on UK's decision to not recognise Covishield

text_fields
bookmark_border

New Delhi: Foreign Secretary Harsh Vardhan Shringla on Monday said that the UK government's decision to not recognise Covishield as a legitimate anti-Covid vaccine is "discriminatory" and it is within the country's "right to take reciprocal measures" if the matter was not resolved,reports

In a press conference in New Delhi, Shringla said that the non-recognition of Covishield is a discriminating policy and impacts Indian citizens travelling to the UK. He also added that the External Affairs Minister has raised the issue strongly with the new UK foreign secretary.

Shringla's comments came on a day Foreign Minister S Jaishankar tweeted about discussing the matter with the British Foreign Secretary Liz Truss on the sidelines of the high-level 76th session of the UN General Assembly.

The meeting in New York took place the same day as the UK announced new Covid-related travel restrictions that sparked sharp criticism and concerns in India.

According to these new rules, Indian travellers who have received both doses of the Covishield vaccine manufactured by the Serum Institute of India (SII) will be considered unvaccinated and will have to undergo self-isolation for 10 days.

Covishield was developed by researchers at the University of Oxford and pharma giant AstraZeneca. It was one of the two vaccines deployed by India -- Covaxin being the other -- in its nationwide Covid vaccination drive launched this January by Prime Minister Narendra Modi.

Covaxin was developed by Hyderabad-based Bharat Biotech in collaboration with the Indian Council of Medical Research.

Show Full Article
TAGS:UKCovid vaccineCovishield
Next Story